These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7503568)

  • 21. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo.
    Barman KD; Khaitan BK; Verma KK
    Dermatol Surg; 2004 Jan; 30(1):49-53. PubMed ID: 14692927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vitiligo in children].
    Lacour JP
    Ann Pediatr (Paris); 1988 May; 35(5):313-9. PubMed ID: 3400965
    [No Abstract]   [Full Text] [Related]  

  • 24. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study.
    Yalçin B; Sahin S; Bükülmez G; Karaduman A; Atakan N; Akan T; Kölemen F
    J Am Acad Dermatol; 2001 Apr; 44(4):634-7. PubMed ID: 11260538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients.
    Radmanesh M; Saedi K
    J Dermatolog Treat; 2006; 17(3):151-3. PubMed ID: 16854754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: A pilot study.
    Reyes E; Jaén P; de las Heras E; Carrión F; Alvarez-Mon M; de Eusebio E; Alvare M; Cuevas J; González S; Villarrubia VG
    J Dermatol Sci; 2006 Mar; 41(3):213-6. PubMed ID: 16423508
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo.
    Buckley DA; Rogers S
    Clin Exp Dermatol; 1996 Jan; 21(1):43-5. PubMed ID: 8689768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
    Vussuki E; Ziv M; Rosenman D; David M
    Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What's new in the treatment of vitiligo.
    Falabella R
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):287-9. PubMed ID: 11730030
    [No Abstract]   [Full Text] [Related]  

  • 31. Helium-neon laser and topical tacrolimus combination therapy: novel treatment option for vitiligo without additional photocarcinogenic risks.
    Lan CC; Wu CS; Chen GS; Yu HS
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):344-5. PubMed ID: 18624863
    [No Abstract]   [Full Text] [Related]  

  • 32. Generalized vitiligo treated by combination therapy of epidermal graft and systemic corticosteroid.
    Lee DY; Choi SC; Lee JH
    Clin Exp Dermatol; 2009 Oct; 34(7):838. PubMed ID: 19663834
    [No Abstract]   [Full Text] [Related]  

  • 33. Segmental vitiligo treated by the combination of epidermal grafting and systemic corticosteroids.
    Lee DY; Lee KJ; Choi SC; Lee JH
    Dermatol Surg; 2010 Apr; 36(4):575-6. PubMed ID: 20402941
    [No Abstract]   [Full Text] [Related]  

  • 34. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of repigmentation in vitiligo after burn injury caused by oral psoralen and ultraviolet A therapy.
    Kim JY; Han BG; Park HJ; Kim YC
    Eur J Dermatol; 2006; 16(4):452-3. PubMed ID: 16935817
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there any treatment of leukotrichia in stable vitiligo?
    Bose SK
    J Dermatol; 1997 Sep; 24(9):615-7. PubMed ID: 9350111
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic interventions for vitiligo.
    Whitton ME; Ashcroft DM; González U
    J Am Acad Dermatol; 2008 Oct; 59(4):713-7. PubMed ID: 18793940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vitiligo].
    Cormane RH; Westerhof W; Siddiqui AH
    Ned Tijdschr Geneeskd; 1984 Sep; 128(39):1855-9. PubMed ID: 6493378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.